Morpheus8

Radiofrequency microneedling · InMode

How it works

Needles 0.5 to 7 mm deep, heat at the tip

EpidermisDermisFat01234567mm0.5 mm1 – 4 mm1 – 7 mm2 – 7 mm
  1. Resurfacing tip0.5 mm
  2. 12-needle tip1 – 4 mm
  3. 24-needle tip1 – 7 mm
  4. 40-needle tip2 – 7 mm

Heat is delivered where the needle tips stop. Deeper settings reach below the dermis.

EpidermisDermisFat01234567mmResurfacing tip0.5 mm12-needle tip1 – 4 mm24-needle tip1 – 7 mm40-needle tip2 – 7 mm

Heat is delivered where the needle tips stop. Deeper settings reach below the dermis.

Four tips, each with its own depth range. Whether the heat makes the dermis remodel is what the published studies measure. Across 39 sites on 10 cadaver faces, the dermis measured 0.76 mm at the upper eyelid to 1.97 mm at the lower side of the nose. Illustrations are schematic.

Can Morpheus8 melt your face fat?

How deep its needles go by tip, why the area decides whether they reach the fat beneath the skin, what the FDA and Health Canada warnings report, and the three questions to ask before a session.

What it costs

Treating the face costs $600 – $1,500 a session on clinic pages

Tap to add or remove an area. Quoted combinations apply where listed.

AreaOne sessionThree-visit budget
$600 – $1,500a session$1,800 – $4,500three-visit budget
upper or lower$600a session$1,800three-visit budget
from $450a sessionfrom $1,350three-visit budget
$600 – $1,035a session$1,800 – $2,700three-visit budget
one price for both$1,000 – $2,000a session$3,000 – $6,000three-visit budget
one price for both$1,000a session$3,000three-visit budget

Budget for three visits

$1,800 – $4,500Three visits on the face, before tax; a budgeting assumption

Published packages or three single visits. The three-visit column uses a published package where one is listed, otherwise three times the single-session price. It is a budgeting assumption, not a prescribed course. No page sells a body area in threes. PRP or exosomes add $200 to $500 a session. Canadian dollars before tax, as the clinic pages state them: thirteen read, six with a price.

Results & duration

Tightening studies added a second device

Neither had an untreated comparison group. Two studies measured tighter skin. Both added a second device, so neither isolates Morpheus8. Dayan 2020: 247 people from clinic records at several centres, treated 2013 to 2018 on “Fractora modified to Morpheus8”, in the paper’s words, with FaceTite, graded by the treating surgeons. Demesh 2021: 9 people, jowls and neck after a facelift, treated with AccuTite as well.

Patient satisfaction

Would do it again

with FaceTite93%of 247 people

Asked by the clinics that treated them, with FaceTite added.

Dayan 2020

Doctor-rated appearance

Looked tighter

with AccuTite55%of 9 people

Rated “marked improvement” at six months on the investigators’ evaluations, which the abstract says were blinded for tightening, with AccuTite, a second device, added.

Demesh 2021

Why the answer is still open

2 of 15

published studies measured tightening

8 of 15

declare a tie to InMode, the maker

5 of 15

have no open full text, so their authors’ ties could not be checked

0 of 2

compared it with no treatment

2 of 2

paired it with a second device

1 of 2

used Morpheus8 rather than Fractora

Every record the searches returned
  • published studies measured tightening: Among all PubMed records listed here, this counts those classified as measuring skin tightening.
  • declare a tie to InMode, the maker: Among all PubMed records listed here, this counts a declared InMode consultancy, sponsorship or holding, including sponsorship documented in a linked trial registration.
  • have no open full text, so their authors’ ties could not be checked: Among all PubMed records listed here, this counts those marked unchecked because no open full text was available to assess ties to InMode.
  • compared it with no treatment: Among the tightening studies, this counts those with a no-treatment or sham comparison group.
  • paired it with a second device: Among the tightening studies, this counts those recorded as combining the radiofrequency microneedling device with another device.
  • used Morpheus8 rather than Fractora: Among the tightening studies, this counts those recorded as using Morpheus8 rather than Fractora, including combination treatments.
  • PubMed · “Morpheus8” and radiofrequency microneedling as a device type · 15
    1. Dayan 2020 · measured tightening · Fractora · 247 people · with FaceTite · a tie to InMode declared
    2. Demesh 2021 · measured tightening · Morpheus8 · 9 people · with AccuTite · a tie to InMode declared
    3. Stein 2025 · assessed adverse events after facial radiofrequency treatments · a tie to InMode declared
    4. Garcés 2025 · measured facial appearance, pore visibility, luminosity and fine wrinkles with nanofat grafting · no tie to InMode declared
    5. Dayan 2021 · measured airborne particle counts and sizes during treatment · no open full text to check
    6. Dayan 2019 · described radiofrequency microneedling combined with FaceTite or BodyTite for skin laxity · a tie to InMode declared
    7. Hamadani 2025 · measured acne relapse after treatment · a tie to InMode declared
    8. Safir 2026 · measured hidradenitis suppurativa severity and treatment response · a tie to InMode declared
    9. Ugonabo 2022 · reported a case series on cellulite treatment · no open full text to check
    10. Cala Uribe 2024 · measured complications, satisfaction and aesthetic outcomes after multidevice arm liposculpture · a tie to InMode declared
    11. O’Daniel 2026 · assessed fibrosis, surgical complexity and neck-lift outcomes after earlier neck treatments · no tie to InMode declared
    12. Sharkov 2024 · described devices used alongside body-contouring surgery · no open full text to check
    13. Magro 2022 · reviewed radiofrequency microneedling technology and applications · no open full text to check
    14. Hendricks 2022 · reviewed Morpheus8 technology and facial dermatology applications · no open full text to check
    15. Hurwitz 2020 · discussed noninvasive and minimally invasive alternatives or additions to abdominoplasty · a tie to InMode declared
  • ClinicalTrials.gov · “Morpheus8” · 7
    1. NCT03945422 · InMode · jowl and neck laxity after a facelift
    2. NCT04103619 · InMode · lower eyelid
    3. NCT05085730 · UT Southwestern · fine lines and wrinkles
    4. NCT03769649 · InMode · cellulite
    5. NCT06283056 · InMode · cellulite
    6. NCT05830968 · InMode · inflammatory acne
    7. NCT05860972 · InMode · axillary hyperhidrosis

How long do results last?

Clinic pages say 12 to 24 months, with a maintenance session at 6 to 18 months. No study has measured it; a review and a randomized split-face trial of other radiofrequency-microneedling devices report skin still remodeling at 6 months.

Tan 2021, PMID 33577211 · Liu 2024, PMID 38923679 · clinic pages

Recovery & risks

Downtime varies with treatment depth

Manual, clinic pages and Dayan 2020 · 247 people

Downtime
1 to 6 days, depending on energy and depth, the operator manual says; 1 to 5 days on three clinic pages, up to 2 weeks on one.
Redness, swelling, crusting
Redness no longer than 24 hours; swelling 1 to 3 weeks; crusting flakes off after 1 to 3 weeks.
Reported in a study
Of 247 people treated with FaceTite added: swelling past six weeks in 12 (4.8%), a hard area past twelve weeks in 8 (3.2%), a weak lower lip for a time in 3 (1.2%); all resolved without further treatment, the paper reports.

Side effects reported to the FDA

No rate established for Morpheus8.

Burns and scarring

Fat loss

Nerve damage

Serious risks reported with RF microneedling · FDA safety communication, passed on by Health Canada · Illustrations are schematic.

Read from the manual, the clinic pages and one study. Downtime of 1 to 6 days, the manual says; swelling for 1 to 3 weeks. InMode’s 2020 operator manual for the course, clinic pages for their days, Dayan 2020 for the counts, with FaceTite added. The FDA’s safety communication names the harms on the cards and gives no count.

Frequently asked questions

Licensed since 2019, when Health Canada added it to InMode’s Class III licence 101725. The licence states no use; the 2020 operator manual this page read states it as “electrocoagulation and hemostasis” (sealing tissue and stopping bleeding), not skin tightening. The FDA cleared the Morpheus8 90 applicator in June 2024, filing K240017, by finding it equivalent to a device already on the market. A licence records Health Canada’s review of the device against its safety and effectiveness requirements for the use filed; it does not establish every benefit, area or duration a clinic advertises.Health Canada · MDALL licence 101725 · InMode manual DO609736B §6.2 · FDA 510(k) K240017

GST or HST applies to taxable cosmetic treatments: 13% in Ontario, 5% where only GST is charged. The clinic prices here are before tax. A treatment for a medical or reconstructive purpose may be exempt when it meets the applicable health-care exemption’s conditions, including who supplies or performs the service; its purpose alone does not establish an exemption.Excise Tax Act · s. 165, Sch. V Pt. II ss. 1, 1.1, 1.2 and 5 to 7, Sch. VIII

A physician, a nurse practitioner, or a nurse working under one. The College of Nurses of Ontario’s guideline on aesthetic services (2026) names microneedling among the services nurses provide, and states that a procedure involving a controlled act needs an order or directive from a nurse practitioner or physician. Two of Ontario’s controlled acts apply: performing a procedure on tissue below the dermis, where the needles work, and applying a prescribed form of energy, since the Controlled Acts regulation prescribes electricity for electrocoagulation, the use the operator manual states. Other provinces set their own rules.CNO · Aesthetic services, practice guideline (2026) · RHPA s. 27(2), paras 2 and 7 · O. Reg. 107/96 s. 1 · InMode manual DO609736B §6.2

Clinic pages quote 3 to 4 sessions, 3 to 6 weeks apart. All 4 pages stating a count quote 3 to 4 for the face; the two stating an interval, and InMode’s operator manual, put 3 to 6 weeks between sessions. The manual’s own range is wider, 1 to 6 sessions, with 3 to 5 for mild to moderate depths.InMode manual DO609736B §§6.8–6.9 · clinic pages, 4 stating a count

One paper, from its authors’ own records. For active acne and early scars, of 139 people treated with Morpheus8, 7 of the 29 followed for three years relapsed, against 36 of 54 on isotretinoin and 12 of 16 after laser. For old scars, 49 people had four sessions of several treatments together with Morpheus8, and their mean scar score went from 178 to 132, so the paper cannot say what Morpheus8 alone did. Its two authors consult for InMode.Hamadani 2025, PMID 39817790

Sources